Profile
Jennifer Dudinak served as the Senior Vice President-Global Regulatory Affairs at Celgene Corp.
from 2018 to 2019.
She received her undergraduate and doctorate degrees from Rutgers University, Camden.
Former positions of Jennifer Dudinak
| Companies | Position | End |
|---|---|---|
| CELGENE | General Counsel | 30/09/2019 |
Training of Jennifer Dudinak
| Rutgers University, Camden | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Jennifer Dudinak
